Amyloid β-peptide (Aβ) has been implicated as a key molecule in the neurodegenerative cascades of Alzheimer's disease (AD). Humanin (HN) is a secretory peptide that inhibits the neurotoxicity of Aβ. However, the mechanism(s) by which HN exerts its neuroprotection against Aβ-induced ADlike pathological changes and memory deficits are yet to be completely defined. In the present study, we provided evidence that treatment of rats with HN increases the number of dendritic branches and the density of dendritic spines, and upregulates pre-and post-synaptic protein levels; these effects lead to enhanced long-term potentiation and amelioration of the memory deficits induced by Aβ 1-42 . HN also attenuated Aβ 1-42 -induced tau hyperphosphorylation, apparently by inhibiting the phosphorylation of Tyr307 on the inhibitory protein phosphatase-2A (PP2A) catalytic subunit and thereby activating PP2A. HN also inhibited apoptosis and reduced the oxidative stress induced by Aβ 1-42 . These fi ndings provide novel mechanisms of action for the ability of HN to protect against Aβ 1-42 -induced AD-like pathological changes and memory defi cits.
INTRODUCTION
Alzheimer's disease (AD) is the most prevalent age-related neurodegenerative disorder and the most common form of senile dementia. It is characterized by deposition of amyloid β (Aβ) plaques, accumulation of intracellular neurofi brillary tangles, and regionalized neuronal dysfunction and dendritic degeneration [1] [2] [3] [4] . The clinical manifestations include a progressive deterioration of memory and cognitive disorders [5] . There is currently no specifi c treatment to stop or reverse the progression of AD.
The Aβ peptides, ranging from 39 to 43 aminoNeurosci Bull December 1, 2014, 30 (6) : [923] [924] [925] [926] [927] [928] [929] [930] [931] [932] [933] [934] [935] 924 acids in length, are generated by enzymatic cleavage of the transmembrane amyloid precursor protein [6] [7] . These peptides are generally believed to be responsible for the cognitive impairment and mental decline in AD patients.
It has been postulated that different soluble or insoluble higher-molecular-weight forms of Aβ trigger a complex pathological cascade that causes synaptic dysfunction, inflammatory processes, neuronal loss, cognitive impairment, and finally the onset of the disease [8] [9] [10] .
Apoptotic cell death is also believed to be involved in Aβ-induced cytotoxicity [11] [12] [13] . Therefore, developing therapeutic strategies that aim to suppress Aβ-induced cytotoxicity has been the main focus of research [14] [15] [16] .
Humanin (HN) is a 24-amino-acid peptide that was identified in the occipital lobe of AD brains [17] . HN suppresses the neurotoxicity of various causative genes for familial AD (FAD) including FAD-related mutant PS1
and PS2 genes [17] [18] [19] , and inhibits the neuronal cell death caused by Aβ [20, 21] . HN is also effective against cell death caused by non-AD-related insults, such as serum deprivation, prion peptide 118-135, and insulin-like growth factor binding protein 3 [22] [23] [24] . However, the neuroprotective effects and mechanism(s) of action of HN on Aβ-induced AD-like pathological changes and memory defi cits in vivo are still not fully described. This study therefore examined the effects of HN against Aβ 42 in vivo and explored the underlying mechanisms in rats.
MATERIALS AND METHODS

Antibodies and Chemicals
The antibodies used are listed in Louis, MO) and were dissolved in normal saline to a fi nal concentration of 5 μg/μL and 100 μmol/L, respectively.
The kits for detecting superoxide dismutase (SOD), 3.0 mm dorsal-ventral according to the rat brain atlas [25] .
Two microliters of Aβ 1-42 (5 μg/μL, 0.2 μL/min) was injected into the hippocampal CA1 region of rats in the Aβ treatment group [26] . In the Aβ 1-42 + HN treatment group, rats were given 2 μL of HN (100 μmol/L) at the same site after injection of Aβ 
Morris Water Maze Test
Spatial memory was assessed using the Morris water maze test on day 7 after injection [27, 28] . Before each experiment (2 h), the rats were brought to the site for habituation.
For spatial learning, rats were trained in the maze to fi nd a submerged platform in four trials per day at 15-min intervals from 14:00 to 20:00 for six consecutive days.
Each training session began by placing the rat in the water in the center of a quadrant and ended when it climbed onto the submerged platform. Rats were left to swim for a fixed time (60 s), after which they were guided to the platform if necessary. During these training sessions, rats acquired learning and spatial memory about the location of the platform. On day 7, the platform was removed and the testing session was performed. The swimming patterns were recorded on each of the 7 days by a video camera connected to a computerized analysis system (Ethovision, Noldus Information Technology, Holland). Using this software, the time taken to reach the hidden platform (latency), the pathway and the length that the rats passed through the target quadrant, and the total times crossing the place where platform was located were acquired. After this spatial memory retention test, rats were euthanized and the hippocampus or the whole brain was harvested for further studies.
Electrophysiological Recording
Rats were anesthetized with urethane (i.p., 1.2-1.5 g/ kg) and fixed in the SR-6N stereotaxic instrument with a bath circulator to maintain the body temperature at 37 ± 0.5°C. A small hole was drilled in the skull and a parallel stimulating/recording electrode was inserted into the right hippocampus. As described previously [29] , the tip of the stimulating electrode was placed in the CA3 area (3.5 mm posterior to bregma, 3.5 mm lateral to the midline, and 3.5 mm below the surface of the skull) and the tip of the recording electrode was positioned in CA1 (4.0 mm posterior to bregma, 2.0 mm lateral to the midline, and 3.0 mm below the surface of the skull).
Detailed electrophysiological recordings were as described previously [30] . Briefl y, initial baseline responses were obtained by delivering a single pulse of stimulation once every 30 s.
In each recording experiment, a stable baseline (<10% change) for at least 30 min was required before application of conditioning stimuli. Long-term potentiation (LTP) at the hippocampal CA3-CA1 synapses was elicited using highfrequency stimulation (ten trains of 20 pulses, 200 Hz, and inter-train interval of 2 s) at the test stimulus intensity.
Western Blotting
Rats were decapitated after the spatial memory retention test. The hippocampi were rapidly removed and homogenized at 4°C using a Tefl on pestle and a glass homogenizer in (in sodium dodecyl sulfate, 40% glycerol, and 40 mmol/L dithiothreitol, boiled for 10 min, and then used for western blotting [31] . 
Golgi Staining
Golgi staining was performed according to methods established in our laboratory [29] . Rats (3 per group) were euthanized by overdose with chloral hydrate (500 mg/kg), and perfused through the aorta with 200 mL 0.9% NaCl containing 0.5% sodium nitrite followed by 500 mL 0.9% NaCl containing 5% formaldehyde. The brain was fi xed in situ by perfusion with 400 mL Golgi fi xative (0.9% NaCl, 5%
formaldehyde, 5% potassium dichromate, and 5% chloral hydrate) under reduced light, then was removed and rapidly processed for Golgi staining under reduced light. Briefly, the brain was postfi xed for 3 days in the same fi xative, and impregnated with 1.0% aqueous silver nitrate for 3 days.
Coronal sections of the hippocampus were imaged using a fl uorescence microscope (Olympus BX60, Tokyo, Japan).
Nissl Staining
Apoptotic events in the CA1 region were monitored using 
Oxidative Stress Assays
The anti-oxidative stress effect of HN in rat hippocampal extracts was determined by measuring the MDA level, and SOD or GSH-PX activity. Rats were sacrificed and the hippocampus was immediately removed and homogenized at 4°C using a Teflon TM glass homogenizer with buffer containing 10 mmol/L Tris-HCl, 0.1 mmol/L EDTA-2Na, 10 mmol/L sucrose, and 0.8% NaCl (pH 7.4).
The homogenates were agitated at 4°C for 6 min and then centrifuged at 12 000 g for 15 min at 4°C. The supernatant was used to determine the MDA level and antioxidant enzyme activity according the manufacturer's instructions.
Electron Microscopy
Sections for electron microscopy were prepared as previously described [32] . In brief, rats were anesthetized and perfused with normal saline followed by 0.5% glutaraldehyde in 4% paraformaldehyde. The brain was removed and placed in 2.5% glutaraldehyde for 12 h at 4°C. The CA1 region was removed from the brain slices. 
Statistical Analysis
Data are presented as mean ± SD and were analyzed using SPSS 12.0 (SPSS Inc., Chicago, IL). One-way analysis of variance, followed by the least significant difference post hoc test, was used to determine signifi cant differences between groups.
RESULTS
HN Attenuates Aβ 1-42 -Induced Cognitive Abnormality
During the training session, the time to find the hidden platform (latency) was signifi cantly increased in rats treated 1A ). In the testing session on day 7, Aβ 1-42 -treated rats were less likely to remain in the quadrant where the platform had been located and, again, rats treated with HN tended to revert to the control behavioral phenotype (Fig. 1B-D) .
These findings demonstrated that HN supplementation attenuates the cognitive defi cits induced by Aβ .
HN Attenuates Aβ 1-42 -Induced LTP Impairment In Vivo
Synaptic plasticity is the functional basis of learning and memory. We found that the population spike amplitude and slope of the fi eld excitatory post-synaptic potential (fEPSP)
were much lower in Aβ 1-42 -treated rats than in control rats (Fig. 2) . Supplementation with HN restored the amplitude and slope of the fEPSP (Fig. 2) . These data suggested that HN mitigates the synaptic transmission defi cits induced by Aβ .
HN Increases the Aβ 1-42 -Induced Reduction in Dendritic Branches and Spine Density in the CA1 Region
To investigate the mechanisms by which HN attenuated the cognitive deficits induced by Aβ 1-42 , the dendritic morphology and dendritic spine density of the pyramidal neurons in the CA1 region were analyzed by Golgi staining.
The average number of dendritic branches was remarkably reduced by Aβ (Fig. 3A, E) ; however, HN increased their number. We also found that Aβ 1-42 treatment reduced the spine density and the percentage of mushroom spines on tertiary branches, while HN ameliorated these spine defi cits (Fig. 3C, F, G ). There were no signifi cant differences in the average length of each branch between the Aβ 1-42 treatment and control groups (Fig. 3A, D) .
HN Inhibits the Decrease of Synaptic Proteins Induced by Aβ 1-42
To further explore the molecular mechanisms involved in the HN-sensitive amelioration of Aβ 1-42 -induced memory deficits, we examined the expression of several memoryassociated proteins in presynaptic neurons. These were synaptophysin, synapsin 1, and synapsin 1 phosphorylated at Ser 9 (p-synapsin 1). Western blot analysis revealed that Aβ 1-42 significantly decreased the levels of all three 
line) and after (solid line) high-frequency stimulation (HFS). B and C: Alterations of LTP represented by normalized amplitude of the population spike (PS) (B) and slope of the fi eld excitatory postsynaptic potential (EPSP) (C). The recordings were started 30 min before HFS (-30).
proteins, while HN reversed all the changes (Fig. 4A, B) . In addition, supplementation with HN signifi cantly attenuated the Aβ 1-42 -induced decrease of the postsynaptic proteins NR2A, NR2B, and PSD95 (Fig. 4C, D) .
HN Attenuates Aβ 1-42 -Induced Tau Hyperphosphorylation by Activation of Protein Phosphatase-2A (PP2A)
Tau hyperphosphorylation is a characteristic feature in the brain of AD patients [33] and it contributes to learning and memory deficits [2] . We measured the effects of HN on the tau phosphorylation induced by Aβ and found a significant increase in the pT205, pS262, pS396, and pS404 residues (Fig. 5A, B) . Decreased immunoreactivity of Tau-1 (the antibody reacts with the epitope of tau nonphosphorylated at Ser198/202) (Fig. 5A, B ) was found in Aβ 1-42 -treated rats, while in rats treated with HN, the Aβ 1-42 -induced changes were significantly reversed (Fig. 5A, B) .
No evident changes were found in total tau probed by Tau-5. These results indicated that HN attenuates Aβ 1-42 -induced tau phosphorylation at multiple AD-related sites in vivo.
We next examined the activity of PP2A, which is most involved in the AD-related changes in tau phosphorylation [34] . We found that the level of PP2A C phosphorylated at Tyr307 (p-PP2A C, inactive form) was increased after Aβ 1-42 injection (Fig. 5C, D) 
HN Prevents Aβ 1-42 -Induced Neuron Apoptosis
Aβ 1-42 is neurotoxic to neurons [6, [35] [36] [37] [38] . Using Nissl staining, we found a signifi cant reduction in the number of surviving neurons after Aβ 1-42 treatment, while HN treatment attenuated this neurotoxicity (Fig. 6A, B) . In addition, we found that treatment with Aβ 1-42 caused an increase in the expression of pro-apoptotic Bax and a decrease in the expression of the anti-apoptotic Bcl-2 protein (Fig.   6C, D) . These changes in expression were both sensitive to HN treatment (Fig. 6C, D) . These data support a neuroprotective role for HN.
HN Reduces Aβ 1-42 -Induced Oxidative Stress
Oxidative stress plays an important role in mediating Aβ 1-42 -induced neurotoxicity [35, 36, 38, 39] . Recent studies have confirmed that HN has a cytoprotective effect against oxidative stress in atherosclerosis [40] . To determine whether HN is also protective against Aβ 1-42 -induced oxidative stress in vivo, the level of MDA, a lipid peroxidation product, and the GSH-PX and SOD activity in the hippocampus were measured. We found that Aβ 1-42 significantly increased the MDA level and decreased the GSH-PX activity, while HN reversed both changes (Fig. 7) . In contrast, the SOD activity was signifi cantly changed only with combined HN and Aβ 1-42 treatment (Fig. 7) . These results implicated the attenuation of oxidative stress in the ability of HN to inhibit Aβ 1-42 -induced neurotoxicity.
HN Attenuates Aβ 1-42 -Induced Ultrastructural Damage in
Hippocampal Neurons
Transmission electron microscopy showed uniformlydistributed rough endoplasmic reticulum (ER) and ribosomes with the presence of large numbers of mitochondria and synapses in control rats (Fig. 8) . In contrast, in hippocampal neurons of rats treated with Aβ 1-42 , the nucleus was irregular in shape, nuclear material was condensed, and the nuclear envelope was 
DISCUSSION
HN is a small molecular-weight peptide that potently functions against AD-related insults by promoting cell survival in vitro [17] . Although the neuroprotective effects of HN are now well known [21, 41] and have been confi rmed in transgenic AD mice [42] , the intrinsic mechanisms by which it suppresses AD-like pathological changes and memory deficits in vivo are still unclear. In the present study, we showed that HN ameliorated the Aβ 1-42 -induced spatial memory defi ciency by reversing LTP impairment, synaptic dysfunction, dendritic degeneration, neuronal apoptosis, oxidative stress, and tau hyperphosphorylation. HN also attenuated the ultrastructural pathological changes induced by Aβ .
It is well recognized that synaptic plasticity, which can be assessed by LTP and/or the morphology of synapses, is an important biological foundation of learning and memory [43] . By measuring the amplitude and slope of the fEPSP, we found that Aβ inhibited the induction of LTP in the hippocampus, whereas simultaneous supplementation with HN ameliorated this inhibition. The synaptic vesicleassociated proteins synaptophysin and synapsin I, putative markers of synaptic plasticity in neuronal networks [44] [45] [46] , Hyperphosphorylation of tau is one of the characteristic features of the AD brain [33, 47] . We confirmed that Aβ significantly increases tau phosphorylation at multiple While some studies have demonstrated that both total and phosphorylated forms of tau are unaffected by Gly 14 -HN treatment in transgenic-AD mice [42] , the present data demonstrated that Aβ 1-42 -induced tau hyperphosphorylation was effi ciently suppressed by simultaneous administration [48, 49] . These data indicate that HN attenuates Aβ 1-42 -induced tau pathology by balancing the effects of upstream protein kinases and phosphatases.
HN infl uences a variety of survival-promoting features:
it protects cerebrovascular smooth muscle cells from Aβ-induced toxicity [50] , and HN or HN-like peptides such as rattin, a rat homologue of HN, are protective against serum withdrawal [51] and N-methyl-D-aspartate-induced excitotoxicity in primary cortical neuronal and glial cocultures [52] . HN negates Aβ-induced neuronal death in vitro [50] . It has been reported that HN inhibits Bax-mediated apoptosis by binding to, and sequestering Bax [53] . To our knowledge, the present in vivo data are the fi rst evidence of HN-mediated neuroprotection against Aβ 1-42 -induced apoptosis that results from the pro-survival expression of
Bcl-2 and Bax proteins.
There is an increasing awareness of the ubiquitous role of oxidative stress in neuropathology [54] and the literature based on animal models and studies of the human brain suggest that oxidative stress plays an important role in neuronal apoptosis in AD [55] . Recently, HN was found to attenuate oxidative stress in atherosclerosis by reducing reactive oxygen species production [40] . We now report that MDA, a marker of oxidative stress, increased, whereas GSH-Px activity decreased in hippocampal extract after Aβ 1-42 injection in vivo, and that HN treatment counteracted these indices of oxidative stress. This would certainly contribute to its neuroprotective profi le in the hippocampus.
Combined with the reported studies, the molecular signaling mechanisms of HN-mediated neuroprotection include stimulation of the PI3 kinase/AKt pathway [56] , inhibition of pro-apoptotic Bcl-2 family members [57] , and modulation of the JAK/STAT pathways [58] by binding to a complex or complexes involving ciliary neurotrophic factor receptor, the IL-27receptor WSX-1, and gp130 [59] .
In summary, we have found that HN attenuates the Aβ 1-42 -induced memory deficits, tau phosphorylation, neuronal dysfunction and dendritic degeneration, and neuronal apoptosis, all of which could ameliorate the neuropsychopathology associated with senile dementia.
